Role of Antimicrobial Peptide Cathelicidin in Thrombosis and Thromboinflammation
Overview
Affiliations
Thrombosis is a frequent cause of cardiovascular mortality and hospitalization. Current antithrombotic strategies, however, target both thrombosis and physiological hemostasis and thereby increase bleeding risk. In recent years the pathophysiological understanding of thrombus formation has significantly advanced and inflammation has become a crucial element. Neutrophils as most frequent immune cells in the blood and their released mediators play a key role herein. Neutrophil-derived cathelicidin next to its strong antimicrobial properties has also shown to modulates thrombosis and thus presents a potential therapeutic target. In this article we review direct and indirect (immune- and endothelial cell-mediated) effects of cathelicidin on platelets and the coagulation system. Further we discuss its implications for large vessel thrombosis and consecutive thromboinflammation as well as immunothrombosis in sepsis and COVID-19 and give an outlook for potential therapeutic prospects.
Yamazaki E, Fujimura T, Takahashi-Watanabe M, Amagai R, Tamabuchi E, Oka K J Clin Med. 2025; 14(4).
PMID: 40004774 PMC: 11856698. DOI: 10.3390/jcm14041243.
Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy.
Man C, An Y, Wang G, Mao E, Ma L J Inflamm Res. 2025; 18():737-750.
PMID: 39845020 PMC: 11752821. DOI: 10.2147/JIR.S495223.
Thrombosis in Critically Ill Influenza Patients: Incidence and Risk Factors.
Qiu X, Liu M, Wang Q, Zhang Y, Kong L, Zhou L Clin Appl Thromb Hemost. 2024; 30:10760296241278615.
PMID: 39183536 PMC: 11348485. DOI: 10.1177/10760296241278615.
Recent advances in the therapeutic potential of cathelicidins.
Guerra M, Vieira B, Calazans A, Destro G, Melo K, Rodrigues E Front Microbiol. 2024; 15:1405760.
PMID: 38989014 PMC: 11233757. DOI: 10.3389/fmicb.2024.1405760.
Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Venom Action.
Serrath S, Pontes A, Paloschi M, Silva M, Lopes J, Boeno C Toxins (Basel). 2023; 15(11).
PMID: 37999488 PMC: 10674320. DOI: 10.3390/toxins15110625.